These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 24199958)

  • 1. Regional white matter hyperintensities: aging, Alzheimer's disease risk, and cognitive function.
    Birdsill AC; Koscik RL; Jonaitis EM; Johnson SC; Okonkwo OC; Hermann BP; Larue A; Sager MA; Bendlin BB
    Neurobiol Aging; 2014 Apr; 35(4):769-76. PubMed ID: 24199958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer's disease.
    Kim JH; Hwang KJ; Kim JH; Lee YH; Rhee HY; Park KC
    J Clin Neurosci; 2011 Aug; 18(8):1101-6. PubMed ID: 21723730
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M;
    Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter hyperintensities mediate gray matter volume and processing speed relationship in cognitively unimpaired participants.
    Brugulat-Serrat A; Salvadó G; Operto G; Cacciaglia R; Sudre CH; Grau-Rivera O; Suárez-Calvet M; Falcon C; Sánchez-Benavides G; Gramunt N; Minguillon C; Fauria K; Barkhof F; Molinuevo JL; Gispert JD;
    Hum Brain Mapp; 2020 Apr; 41(5):1309-1322. PubMed ID: 31778002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of white matter hyperintensities and gray matter volume with cognition in older individuals without cognitive impairment.
    Arvanitakis Z; Fleischman DA; Arfanakis K; Leurgans SE; Barnes LL; Bennett DA
    Brain Struct Funct; 2016 May; 221(4):2135-46. PubMed ID: 25833685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
    Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
    J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
    Low A; Ng KP; Chander RJ; Wong B; Kandiah N
    J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of age and apolipoprotein E ε4 status on regional white matter hyperintensity volume and cognition in healthy aging.
    Van Etten EJ; Bharadwaj PK; Grilli MD; Raichlen DA; Hishaw GA; Huentelman MJ; Trouard TP; Alexander GE
    J Int Neuropsychol Soc; 2024 Jul; 30(6):553-563. PubMed ID: 38515367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White Matter Hyperintensities and Apolipoprotein E Affect the Association Between Mean Arterial Pressure and Objective and Subjective Cognitive Functioning in Older Adults.
    Jung Y; Viviano RP; van Rooden S; van der Grond J; Rombouts SARB; Damoiseaux JS
    J Alzheimers Dis; 2021; 84(3):1337-1350. PubMed ID: 34657884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between white matter hyperintensity load and grey matter atrophy in mild cognitive impairment is not unidirectional.
    Vipin A; Wong BYX; Kumar D; Low A; Ng KP; Kandiah N
    Aging (Albany NY); 2021 Apr; 13(8):10973-10988. PubMed ID: 33861727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD.
    Yoshita M; Fletcher E; Harvey D; Ortega M; Martinez O; Mungas DM; Reed BR; DeCarli CS
    Neurology; 2006 Dec; 67(12):2192-8. PubMed ID: 17190943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracting and summarizing white matter hyperintensities using supervised segmentation methods in Alzheimer's disease risk and aging studies.
    Ithapu V; Singh V; Lindner C; Austin BP; Hinrichs C; Carlsson CM; Bendlin BB; Johnson SC
    Hum Brain Mapp; 2014 Aug; 35(8):4219-35. PubMed ID: 24510744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral small vessel disease in aging and Alzheimer's disease: a comparative study using MRI and SPECT.
    Makedonov I; Black SE; MacIntosh BJ
    Eur J Neurol; 2013 Feb; 20(2):243-50. PubMed ID: 22742818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOE ε4 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role?
    Brickman AM; Schupf N; Manly JJ; Stern Y; Luchsinger JA; Provenzano FA; Narkhede A; Razlighi Q; Collins-Praino L; Artero S; Akbaraly TN; Ritchie K; Mayeux R; Portet F
    Alzheimers Dement; 2014 Nov; 10(6):619-29. PubMed ID: 25304991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional quantification of white matter hyperintensity in normal aging, mild cognitive impairment, and Alzheimer's disease.
    Chen YF; Wang H; Chu Y; Huang YC; Su MY
    Dement Geriatr Cogn Disord; 2006; 22(2):177-84. PubMed ID: 16912479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial patterns of white matter hyperintensities associated with Alzheimer's disease risk factors in a cognitively healthy middle-aged cohort.
    Salvadó G; Brugulat-Serrat A; Sudre CH; Grau-Rivera O; Suárez-Calvet M; Falcon C; Fauria K; Cardoso MJ; Barkhof F; Molinuevo JL; Gispert JD;
    Alzheimers Res Ther; 2019 Jan; 11(1):12. PubMed ID: 30678723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small vessel cerebrovascular disease is associated with cognition in prospective Alzheimer's clinical trial participants.
    Morales CD; Cotton-Samuel D; Lao PJ; Chang JF; Pyne JD; Alshikho MJ; Lippert RV; Bista K; Hale C; Edwards NC; Igwe KC; Deters K; Zimmerman ME; Brickman AM
    Alzheimers Res Ther; 2024 Feb; 16(1):25. PubMed ID: 38308344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence.
    Brickman AM; Zahodne LB; Guzman VA; Narkhede A; Meier IB; Griffith EY; Provenzano FA; Schupf N; Manly JJ; Stern Y; Luchsinger JA; Mayeux R
    Neurobiol Aging; 2015 Jan; 36(1):27-32. PubMed ID: 25155654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between magnetic resonance imaging measures and neuropsychological impairment in early and late onset alzheimer's disease.
    van der Vlies AE; Staekenborg SS; Admiraal-Behloul F; Prins ND; Barkhof F; Vrenken H; Reiber JH; Scheltens P; van der Flier WM
    J Alzheimers Dis; 2013; 35(1):169-78. PubMed ID: 23364136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.